Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Rune Nielsen, Hannu Kankaanranta, Leif Bjermer, Peter Lange, Sofie Arnetorp, Morten Hedegaard, Anna Stenling, Nicole Mittmann

    7 Citationer (Scopus)

    Abstract

    Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).
    OriginalsprogEngelsk
    TidsskriftRespiratory medicine
    Vol/bind107
    Udgave nummer11
    Sider (fra-til)1709-21
    Antal sider13
    ISSN0954-6111
    DOI
    StatusUdgivet - nov. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries'. Sammen danner de et unikt fingeraftryk.

    Citationsformater